Cipla will market Eli Lilly’s diabetes and weight-loss drug Mounjaro as Yurpeak in India, enhancing accessibility and ...
Eli Lilly has signed a licensing deal with Cipla to market its blockbuster weight-loss drug under the brand name Yurpeak in ...
India Today on MSN
Maker of blockbuster weight-loss drug Mounjaro ties up with Cipla to reach small-town India
US-based pharma giant Eli Lilly’s blockbuster weight-loss drug, Mounjaro, is set to expand its reach across India through a ...
IT’S not your imagination – everyone really is getting thinner. From the girls’ WhatsApp chat to your gym’s changing room, ...
Eli Lilly's launch of Mounjaro in India in March 2025 was the first step of Tirzepatide in the country. In June 2025, the ...
Eli Lilly has teamed up with Cipla to market its popular weight-loss drug Mounjaro in India. The medication, which is used ...
Karen McGonigal, 53, died days after she was illegally administered a dose of semaglutide - the powerful ingredient behind Ozempic and Wegovy - in May.
Eli Lilly signed an agreement with Cipla , allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a ...
In a move aimed at expanding access to obesity and diabetes care in India, Eli Lilly and Company (India) Pvt. Ltd. (Lilly) ...
India has about 101 million people living with diabetes and nearly half of these in the adult patients category are being ...
Eli Lilly and Cipla have joined forces. Cipla will now market Lilly's popular weight-loss drug in India. The medication will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback